Carter Robert Ross 4
4 · Oncology Institute, Inc. · Filed Jan 7, 2025
Insider Transaction Report
Form 4
Carter Robert Ross
Chief Financial Officer
Transactions
- Disposition to Issuer
Class A Common Stock
2025-01-06$0.34/sh−258$86→ 31,501 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of restricted stock units (RSUs) pursuant to a sell-to-cover provision included in the RSU Agreement.
- [F2]Price is the volume weighted average selling price of all sales by the Reporting Person on January 6, 2025 within a one-dollar range. Actual prices ranged from $0.293 to $0.335. The Reporting Person hereby undertakes to provide upon request of the Commission staff full information regarding the number of shares sold at each separate price.